Checkpoint Blockade Therapy Clears Safety Hurdle for Patients With HIV and Cancer
Published: Thursday, Jan 25, 2018
Thomas S. Uldrick, MD
Although there has been reluctance among oncology researchers to administer immunotherapy to patients with HIV who develop cancer, early signals from a small clinical trial suggest that such a strategy may be safe in certain settings.
... to read the full story